AARTIDRUGS

Aarti Drugs Share Price Aarti Drugs

₹434.3
-6.5 (-1.47%)
28 March, 2024 22:40 BSE: 524348 NSE: AARTIDRUGSISIN: INE767A01016

Start SIP in Aarti Drugs

Start SIP

Aarti Drugs Performance

Day Range

  • Low 431
  • High 451
₹ 434

52 Week Range

  • Low 332
  • High 646
₹ 434
  • Open Price441
  • Previous Close441
  • Volume461430

Aarti Drugs Share Price

  • Over 1 Month -13.26%
  • Over 3 Month -11.98%
  • Over 6 Month -19.74%
  • Over 1 Year 24.57%

Aarti Drugs Key Statistics

P/E Ratio 22.2
PEG Ratio 2.5
Market Cap Cr 3,993
Price to Book Ratio 3.3
EPS 16.6
Dividend 0.2
Relative Strength Index 29.2
Money Flow Index 20.43
MACD Signal -17.97
Average True Range 15.24
Aarti Drugs Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 538578592696
Operating Expenses Qtr Cr 478512520608
Operating Profit Qtr Cr 60657289
Depreciation Qtr Cr 12121212
Interest Qtr Cr 7888
Tax Qtr Cr 11121416
Net Profit Qtr Cr 32354053
IndicatorMar 2023
Total Revenue Annual Cr 2,500
Operating Expenses Annual Cr 2,216
Operating Profit Annual in Cr 282
Depreciation Cr 47
Interest Annual Cr 33
Tax Annual Cr 52
Net Profit Annual Cr 153
IndicatorMar 2023
Cash from Operating Activity Annual Cr 162
Cash from Investing Activity Annual Cr -131
Cash from Financing Annual Activity Cr -31
Net Cash Flow Annual Cr 1
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,114
Fixed Assets Annual Cr 795
Total Non Current Assets Annual Cr 846
Total Current Assets Annual Cr 1,350
Total Assets Annual Cr 2,195
IndicatorMar 2023
Book Value Per Share Annual Rs 120
ROE Annual % 14
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 606642661742
Operating Expenses Qtr Cr 536565577649
Operating Profit Qtr Cr 70768494
Depreciation Qtr Cr 13131313
Interest Qtr Cr 8899
Tax Qtr Cr 15171617
Net Profit Qtr Cr 37404856
IndicatorMar 2023
Total Revenue Annual Cr 2,718
Operating Expenses Annual Cr 2,410
Operating Profit Annual in Cr 306
Depreciation Cr 50
Interest Annual Cr 33
Tax Annual Cr 58
Net Profit Annual Cr 166
IndicatorMar 2023
Cash from Operating Activity Annual Cr 134
Cash from Investing Activity Annual Cr -164
Cash from Financing Annual Activity Cr 17
Net Cash Flow Annual Cr -13
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 1,192
Fixed Assets Annual Cr 887
Total Non Current Assets Annual Cr 929
Total Current Assets Annual Cr 1,492
Total Assets Annual Cr 2,421
IndicatorMar 2023
Book Value Per Share Annual Rs 129
ROE Annual % 14
ROCE Annual % 17
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 11

Aarti Drugs Technicals

EMA & SMA

Current Price
₹434.3
-6.5 (-1.47%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹463.64
  • 50 Day
  • ₹486.81
  • 100 Day
  • ₹497.09
  • 200 Day
  • ₹496.03
  • 20 Day
  • ₹464.80
  • 50 Day
  • ₹502.21
  • 100 Day
  • ₹497.07
  • 200 Day
  • ₹513.49

Aarti Drugs Resistance and Support

PIVOT
₹438.62
Resistance
First Resistance 446.18
Second Resistance 458.07
Third Resistance 465.63
RSI 29.20
MFI 20.43
MACD Single Line -17.97
MACD -19.03
Support
First Resistance 426.73
Second Resistance 419.17
Third Resistance 407.28

Aarti Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 500,988 27,444,123 54.78
Week 440,329 21,576,121 49
1 Month 201,148 9,741,586 48.43
6 Month 353,598 12,789,627 36.17

Aarti Drugs Result Highlights

Aarti Drugs Synopsis

NSE-Medical-Diversified

Aarti Drugs Ltd is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2497.97 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2023. Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433.
Market Cap 4,064
Sales 2,404
Shares in Float 3.95
No of funds 88
Yield 0.23
Book Value 3.66
U/D Vol ratio 1.2
LTDebt / Equity 15
Alpha
Beta 0.89

Aarti Drugs

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 57.47%58.56%58.7%59.58%
Mutual Funds 5.18%5.22%4.63%4.01%
Insurance Companies 0.08%0.1%0.08%0.08%
Foreign Portfolio Investors 2.1%2.33%1.97%1.94%
Financial Institutions/ Banks
Individual Investors 25.84%24.65%25.35%25.72%
Others 9.33%9.14%9.27%8.67%

Aarti Drugs Management

Name Designation
Mr. Chandrakant V Gogri Chairman Emeritus
Mr. Prakash M Patil Chairman & M.D & CEO
Mr. Rashesh C Gogri Managing Director
Mr. Harshit M Savla Joint Managing Director
Mr. Harit P Shah Executive Director
Mr. Uday M Patil Executive Director
Mrs. Neha R Gada Independent Director
CA. Navin C Shah Independent Director
Dr. Krishnacharya G Akamanchi Independent Director
Prof. Bhaskar N Thorat Independent Director
Mrs. Priti P Savla Independent Director
Mr. Ankit V Paleja Independent Director
Mr. Narendra J Salvi Non Executive Director

Aarti Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarti Drugs Corporate Action

Date Purpose Remarks
2024-01-24 Quarterly Results & Interim Dividend
2023-10-19 Quarterly Results
2023-07-21 Quarterly Results & Buy Back
2023-04-29 Audited Results
2023-01-27 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-02-06 INTERIM Rs.1.00 per share(10%)Interim Dividend
2023-02-08 INTERIM Rs.1.00 per share(10%)Interim Dividend
2022-02-10 INTERIM Rs.1.00 per share(10%)Interim Dividend

Aarti Drugs FAQs

What is Share Price of Aarti Drugs ?

Aarti Drugs share price is ₹434 As on 28 March, 2024 | 22:26

What is the Market Cap of Aarti Drugs ?

The Market Cap of Aarti Drugs is ₹3992.7 Cr As on 28 March, 2024 | 22:26

What is the P/E ratio of Aarti Drugs ?

The P/E ratio of Aarti Drugs is 22.2 As on 28 March, 2024 | 22:26

What is the PB ratio of Aarti Drugs ?

The PB ratio of Aarti Drugs is 3.3 As on 28 March, 2024 | 22:26

Q2FY23